Profile data is unavailable for this security.
About the company
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
- Revenue in EUR (TTM)45.76m
- Net income in EUR-4.30m
- Incorporated2021
- Employees177.00
- LocationApontis Pharma AGRolf-Schwarz-Schuette-Platz 1Monheim Am Rhein 40789GermanyDEU
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera AG | 21.67m | -2.57m | 16.74m | 80.00 | -- | 0.9376 | -- | 0.7725 | -0.4146 | -0.4146 | 3.81 | 2.94 | 0.8376 | 1.14 | 13.28 | 246,261.40 | -9.93 | -11.99 | -14.14 | -15.19 | 75.61 | 84.28 | -11.85 | -20.93 | 1.45 | -1.27 | 0.0494 | -- | 25.30 | 8.85 | 99.16 | -- | 12.20 | -- |
| B.M.P. Pharma Trading AG | -100.00bn | -100.00bn | 28.97m | 45.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.68 | -- | 17.58 | -- | 0.2347 | -- | 87,097.18 | -- | -- | -- | -- | -96.34 | -61.60 | 75.39 | 43.01 | -- | -- |
| Viromed Medical AG | 0.00 | -80.36k | 50.40m | -- | -- | 1.92 | -- | -- | -0.004 | -0.004 | 0.00 | 0.9789 | 0.00 | -- | -- | -- | -0.399 | -- | -0.399 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 31.26 | -- | -- | -- |
| Haemato AG | 260.81m | 9.61m | 73.44m | 78.00 | 7.06 | 0.4534 | 6.82 | 0.2816 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Apontis Pharma AG | 45.76m | -4.30m | 82.45m | 177.00 | -- | 2.60 | -- | 1.80 | -0.4819 | -0.4819 | 5.36 | 3.73 | 0.9564 | 3.04 | 15.78 | 258,552.60 | -8.99 | -- | -10.12 | -- | 58.50 | -- | -9.40 | -- | 2.74 | -- | 0.00 | -- | -33.67 | -- | -520.38 | -- | -- | -- |
| PharmaSGP Holding SE | 109.76m | 18.21m | 302.40m | 93.00 | 16.60 | 9.27 | 10.96 | 2.76 | 1.52 | 1.52 | 9.15 | 2.72 | 0.8223 | 1.04 | 8.57 | 1,233,225.00 | 13.64 | 13.70 | 18.34 | 19.98 | 90.91 | 90.20 | 16.59 | 17.56 | 1.54 | 14.98 | 0.6823 | -- | 17.80 | 10.78 | 37.17 | 2.16 | 25.88 | -- |
| Medios AG | 1.84bn | 12.88m | 374.42m | 1.00k | 27.56 | 0.7378 | 9.39 | 0.2033 | 0.5326 | 0.5326 | 76.07 | 19.90 | 2.39 | 23.11 | 12.28 | 3,576,214.00 | 1.67 | 3.40 | 2.36 | 4.07 | 7.19 | 6.05 | 0.699 | 1.01 | 0.7551 | 5.97 | 0.3174 | 0.00 | 10.80 | 40.34 | 2.62 | 34.17 | -7.11 | -- |
Data as of Nov 15 2024. Currency figures normalised to Apontis Pharma AG's reporting currency: Euro EUR
18.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kreissparkasse Biberachas of 31 Jul 2024 | 647.50k | 7.62% |
| UBS Asset Management (UK) Ltd.as of 30 Apr 2024 | 227.20k | 2.67% |
| Deka Investment GmbHas of 31 May 2024 | 221.49k | 2.61% |
| Ehrke & L�bberstedt AGas of 31 Aug 2024 | 125.00k | 1.47% |
| LOYS AGas of 30 Jun 2024 | 98.65k | 1.16% |
| GVC Gaesco Gesti�n SGIIC SAas of 30 Sep 2024 | 72.00k | 0.85% |
| Do Investment AGas of 31 Dec 2023 | 52.12k | 0.61% |
| Aktia Varainhoito Oyas of 30 Sep 2024 | 40.00k | 0.47% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 36.34k | 0.43% |
| GS&P Kapitalanlagegesellschaft SAas of 31 Dec 2023 | 30.00k | 0.35% |
More ▼
Data from 31 Dec 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
